Hebei Changshan Biochemical Pharmaceutical Co., Ltd.(300255.SZ)
Registered Capital:
108.00(RMB MLN)
Introduction from Google Finance
Hebei Changshan Biochemical Pharmaceutical Co., Ltd is principally engaged in the research, development, manufacture and distribution of pharmaceutical products. The Company primarily provides heparinum product series. The Company provides sodium heparin pharmaceutical raw materials, including products for injection and non-injection, as well as low-molecular-weight heparin calcium for injection and sodium heparin for injection. The Company's products are applied primarily in the prevention and treatment of cerebral vascular diseases, hardened arteries, myocardial infarction, phlebitis, chilblains, ulcer and eczema, among others. It distributes its products in domestic and overseas markets.
News      more..
Introduction from Company WebSite

Hebei Changshan Biochemical Pharmaceutical Co. Ltd. (hereinafter called Changshan Pharm) established in Sep. 28, 2000 and grew out of Hebei Changshan Limited Company. From the very beginning, Changshan Pharm has been endeavored in the researching & developing, producing and sale of heparin products and gradually led around China in heparin API and preparation.
Changshan Pharm has been a State-level hi-tech enterprise in biochemical pharmaceutics since September 2009. It is also the first pharmaceutical enterprise as innovation investment pilot by the National Development and Reform Commission and the Ministry of Finance, and it has been listed in the China 12th Five-Year Plan for significant new drugs creation. Since the establishment, Changshan Pharm has been awarded “Excellent Private Hi-tech Enterprise in Hebei Province”, “Excellent Private Enterprise in Hebei Province”, “Leading Enterprise in Agricultural Industrialization Operation in Hebei Province”, “Export Brand Enterprise in Hebei Province”, etc. Its products have been awarded Prize for Progress in Science and Technology in provincial and city level for many times.

The workshops of Changshan Pharm for producing API, small volume injectio, tablet and hard capsule owned GMP certificate and work in strict accordance with the requirements in GMP as to production and process flow. In October 2008, the workshop for heparin API acquired European CEP certificate and French GMP certificate in 2009.

Changshan Pharm mainly engages in the researching & developing, producing and sale of heparin products, having a complete industry chain for heparin products. It is one of the top enterprises in researching & developing, producing and sale of both heparin sodium API and heparin preparation. Its primary products include heparin sodium API, LMW heparin calcium injectio, heparin sodium injectio, sodium hyaluronate, hard capsule and Yihaitang capsule, an anti-aging health product.
It is the modern production equipments & detecting instruments which are brought from Germany, United States, Italy, etc. and the technologies with independent intellectual property rights that enable the products meet the requirements of high-end oversea market. The quality control system is of international level, enabling a reliable and stable product quality and a better sale over 30 countries and districts around the world.

Integrity-oriented and win-win business is the core concept of Changshan Pharm. We are looking forward to serving and cooperating with partners from all over the world on the basis of excellent products, services and efficiency.

2005-2014 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号